BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

New York, February 6, 2026, 09:03 EST — Premarket

  • BitMine Immersion shares climbed roughly 9% in premarket, bouncing back from a 14% plunge the day before.
  • Ether slipped about 5% during the day, adding to the strain on crypto-linked stocks.
  • Traders are eyeing crypto prices ahead of the open and the company’s next earnings report set for April 29.

Shares of BitMine Immersion Technologies Inc climbed 8.7% to $18.91 in premarket trading Friday, clawing back some losses from the previous session. Investors kept an eye on ether, the crypto token that’s central to the company’s balance sheet, which slipped further. 1

The erratic trading matters because “digital asset treasury” stocks have become a quick, leveraged way to bet on crypto moves via U.S.-listed equities. That trade is now under pressure as risk appetite wanes. “It’s clear the crypto market is now in full capitulation mode,” said Nic Puckrin, investment analyst and Coin Bureau co-founder. 2

Thursday’s sharp drop in Bitcoin weighed heavily on the market, pushing the broader crypto sector lower and souring sentiment across risk assets, Reuters reported. The selloff also intersected with raw swings in precious metals and a broader tech sector slump, the report added. 3

Ether dropped nearly 5%, settling near $1,955 after dipping to a low of $1,757. Bitcoin slipped roughly 3%, hovering around $67,421.

BitMine closed Thursday at $17.40, slipping 14.3% during the session. 4

The company has positioned itself as an “Ethereum treasury” play. In a filing dated Feb. 2, BitMine reported holding 4,285,125 ether tokens as of Feb. 1, with a significant share staked—locking up tokens to support network operations in return for rewards.

The filing also revealed the company’s intention to roll out its MAVAN (Made-in America VAlidator Network) staking infrastructure by Q1 2026.

Investors have been watching the company’s capital flexibility closely. In a Jan. 15 filing, shareholders approved a charter amendment that boosts authorized common shares from 500 million to 50 billion, along with other measures. 5

In premarket trading Friday, crypto-linked stocks took a hit. Coinbase Global dropped roughly 13%, Strategy slid about 17%, and miners Marathon Digital and Riot Platforms tumbled around 18% and 15%, respectively.

BitMine’s stock can be volatile, moving sharply up or down, and dilution is still a real concern. The company cautioned in its proxy documents that issuing more authorized shares risks diluting current shareholders and could “adversely affect” the stock price. 6

Traders are eyeing whether ether can push back above $2,000 as markets open and how crypto holds up heading into next week. BitMine is set to release its next earnings report on April 29, per WSJ market data. 7

Stock Market Today

  • Corn Futures Slip Slightly Friday Amid Export Sales and Trade Developments
    February 6, 2026, 10:34 AM EST. Corn futures edged lower early Friday after gains in the previous session, with September contracts falling below $4.0, despite strong export sales to countries like Colombia, South Korea, and Japan. The USDA reported old crop corn sales of 340,924 metric tons for the week ending July 24, more than double last year's volume. New crop bookings hit a marketing year high of 1.892 million metric tons. Trade developments including a U.S.-South Korea tariff deal and a tariff pause extension with Mexico added complexity to market sentiment. Cash corn prices rose 2 cents to $3.76 3/4, reflecting ongoing demand amid fluctuating futures. Open interest increased by 11,766 contracts, signaling active trader participation.
Stellantis’ $26.5 billion EV reset jolts markets as carmakers rack up $55 billion in rollbacks
Previous Story

Stellantis’ $26.5 billion EV reset jolts markets as carmakers rack up $55 billion in rollbacks

Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst
Next Story

Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Go toTop